Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$928K Buy
2,638
+80
+3% +$28.5K 0.27% 98
2025
Q4
$837K Buy
2,558
+4
+0.2% +$1.27K 0.24% 104
2025
Q3
$721K Buy
2,554
+30
+1% +$8.7K 0.22% 108
2025
Q2
$705K Buy
+2,524
New +$715K 0.24% 112

Other funds holding AMGN

LOM Asset Management's AMGN Position: Q1 2026 in Review

LOM Asset Management increased its Amgen (AMGN) stake by 3.1% in Q1 2026, buying an estimated $28.5K and bringing the position to 2,638 shares worth $928K. The position accounts for 0.27% of the portfolio, ranked #98.

LOM Asset Management first reported a position in AMGN in Q2 2025 and has held it in 4 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • LOM Asset Management held 2,638 shares of Amgen worth $928K as of Q1 2026.
  • LOM Asset Management bought 80 Amgen shares in Q1 2026, an estimated $28.5K.
  • Amgen made up 0.27% of LOM Asset Management's portfolio in Q1 2026, its #98 holding.
  • LOM Asset Management first reported a position in Amgen in Q2 2025 and has held it in 4 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on LOM Asset Management's 13F filing for Q1 2026, filed 5 May 2026.